http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
열전모듈을 이용한 냉방기의 최적 운전조건에 관한 실험적 연구
황준,강병하 대한설비공학회 2006 설비공학 논문집 Vol.18 No.1
This article presents the optimal operation of an air conditioner using thermoelectric modules. A prototype of air conditioner using four thermoelectric modules has been designed and built. The system performance with evaporative cooling for hot side of the module are studied in detail for several operating parameters, such as input power to the thermoelectric module, fans and pump. It is found that the optimal input voltage to the thermoelectric module and pump is selected for the best system performance based on the cooling capacity and the COP at a given operating condition. It is also found that both the cooling capacity and COP of a system is increased with an increase in the input power to fans. The cooling performance could be improved when the ambient temperature is increased and the relative humidity is decreased since the evaporative cooling at the hot side has been increased.
황준일,심현정,박영규,조상희,배우균,김대은,김경근,정익주 대한의학회 2011 Journal of Korean medical science Vol.26 No.11
KITENIN (KAI1 C-terminal interacting tetraspanin) promotes invasion and metastasis in mouse colon cancer models. In the present study, we evaluated the effects of KITENIN knockdown by intravenous administration of short hairpin RNAs (shRNAs) in an orthotopic mouse colon cancer model, simulating a primary or adjuvant treatment setting. We established orthotopic models for colon cancer using BALB/c mice and firefly luciferaseexpressing CT-26 (CT26/Fluc) cells. Tumor progression and response to therapy were monitored by bioluminescence imaging (BLI). In the primary therapy model, treatment with KITENIN shRNA substantially delayed tumor growth (P = 0.028) and reduced the incidence of hepatic metastasis (P = 0.046). In the adjuvant therapy model, KITENIN shRNA significantly reduced the extent of tumor recurrence (P = 0.044). Mice treated with KITENIN shRNA showed a better survival tendency than the control mice (P = 0.074). Our results suggest that shRNA targeting KITENIN has the potential to be an effective tool for the treatment of colon cancer in both adjuvant and metastatic setting.
황준일,조상희,심현정,이세련,양덕환,김여경,이제중,김형준,정익주,안재숙 대한의학회 2008 Journal of Korean medical science Vol.23 No.4
This phase II study evaluated the efficacy and safety of combination chemotherapy with paclitaxel, cisplatin, and 5-fluorouracil (5-FU) in advanced gastric cancer. Patients with histologically confirmed gastric adenocarcinoma were eligible for the study. Paclitaxel (175 mg/㎡) and cisplatin (75 mg/㎡) were given as a 1-hr intravenous infusion on day 1, followed by 5-FU (750 mg/㎡) as a 24-hr continuous infusion for 5 days. This cycle was repeated every 3 weeks. Forty-five eligible patients (median age, 56 yr) were treated in this way. Of the 41 patients in whom efficacy was evaluable, an objective response rate (ORR) was seen in 51.2% (95% CI, 0.35-0.67), a complete response in two, and a partial response in 19 patients. The median progression free survival was 6.9 months (95% CI, 5.86-7.94 months), and the median overall survival was 12.7 months (95% CI, 9.9-15.5). The main hematological toxicity was neutropenia and greater than grade 3 neutropenia was observed in twelve patients (54%). Febrile neutropenia developed in three patients (6.8%). The major non-hematological toxicities were asthenia and peripheral neuropathy, but most of patients showed grade 1 or 2. In conclusion, combination chemotherapy with paclitaxel, cisplatin, and 5-FU is a promising regimen, and was well tolerated in patients with advanced gastric cancer.